L05-EXd

Overview

L05-EXd is a toxin-linker conjugate, in which the toxin component is Exatecan ( HY-13631 ). L05-EXd can be conjugated with Polatuzumab ( HY-P99042 ) to form the ADC molecule Polatuzumab -L05-EXd. L05-EXd is applicable to research related to small cell lung cancer and non-small cell lung cancer .

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Respiratory Disease | Products > Disease Areas > Lung Cancer | Products > Disease Areas > Respiratory Cancer | Products > Disease Areas > Small Cell Lung Cancer | Products > Disease Areas > Non-Small Cell Lung Cancer | Products > Signaling Pathways > Antibody-Drug Conjugate/ADC Related | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > Drug-Linker Conjugates for ADC

Product Information

• Catalog No.: HY-184561
• CAS No.: 3128805-51-3
• Molecular Formula: C64H76FN9O25
• Molecular Weight: 1390.33
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source